Oxycodone/paracetamol controlled release

Drug Profile

Oxycodone/paracetamol controlled release

Alternative Names: DDS-06B; DDS-08B; oxycodone/acetaminophen - Labopharm; Oxycodone/paracetamol - INTELLITAB™

Latest Information Update: 31 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Labopharm
  • Developer Endo International
  • Class Acetanilides; Antipyretics; Antirheumatics; Morphine derivatives; Non-opioid analgesics; Opioid analgesics
  • Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists; Prostaglandin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
  • 07 Oct 2011 Labopharm has been acquired by Paladin Labs
  • 07 May 2011 Oxycodone/paracetamol is available for licensing (http://www.labopharm.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top